Evidence map›Paper›PMID 42482117›Full record

ReviewHuman genomics2026

ExposoGenomics: integrating genome and exposome as jointly dynamic systems for causal discovery and precision health.

Vasilis Vasiliou, Nicholas Katsanis, Giuseppe Novelli, Juergen K V Reichardt, Bassam R Ali, Maria Gazouli, Sek Won Kong, Hongyu Zhao, Kiril Veselkov, Bhramar Mukherjee and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Human genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vasilis VasiliouDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA. vasilis.vasiliou@yale.edu.
Nicholas KatsanisGalatea Bio, Miami, FL, and Institute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology-Hellas (FORTH), Heraklion, Crete, Greece.
Giuseppe NovelliDepartment of Biomedicine and Prevention, Tor Vergata University of Rome, Rome, Italy.
Juergen K V ReichardtAustralian Institute of Tropical Health and Medicine, James Cook University, Smithfield, QLD, Australia.
Bassam R AliDepartment of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
Maria GazouliDepartment of Basic Medical Science, Laboratory of Biology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Sek Won KongComputational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.
Hongyu ZhaoDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
Kiril VeselkovDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA.
Bhramar MukherjeeDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
Dimosthenis SarigiannisDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The past decade has witnessed an unprecedented convergence of exposomic technologies, population-scale genomics, and AI-enabled data science, creating the conditions for a new integrative discipline. Here we introduce ExposoGenomics, defined as the integrative study of how the genome and exposome, treated as jointly dynamic systems, interact across the life course to shape health and disease. ExposoGenomics moves beyond classical gene-environment interaction models by embedding high-dimensional, temporally resolved exposure data within a multi-omic and AI-enabled analytical architecture oriented toward causal discovery, mechanistic understanding, and translational application. We describe the conceptual foundations of this framework, its mechanistic architecture linking external exposures to genomic responses through physiologically based kinetic models and adverse outcome networks, and the analytical approaches, including causal machine learning, graph-based integration, and foundation models, required to realize its potential. We emphasize that computational prediction must be accompanied by rigorous empirical validation, and that findings must be grounded in biologically plausible, causally supported mechanisms. In conjunction with this Perspective, Human Genomics formally launches ExposoGenomics as a dedicated article category and invites submissions that advance this integrative agenda.

Indexed as

ExposomeGenome, HumanGenomicsPrecision MedicineGene-Environment InteractionHumansMachine LearningMultiomicsAdverse outcome networksCausal inferenceExposomeGenome–exposome interactionsMachine learningMulti-omicsPhysiologically based kinetic (PBK) modellingPrecision preventionPreconception exposomeTranslational exposomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.